206 related articles for article (PubMed ID: 12218052)
1. Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion.
Barbouche R; Miquelis R; Jones IM; Fenouillet E
J Biol Chem; 2003 Jan; 278(5):3131-6. PubMed ID: 12218052
[TBL] [Abstract][Full Text] [Related]
2. Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry.
Markovic I; Stantchev TS; Fields KH; Tiffany LJ; Tomiç M; Weiss CD; Broder CC; Strebel K; Clouse KA
Blood; 2004 Mar; 103(5):1586-94. PubMed ID: 14592831
[TBL] [Abstract][Full Text] [Related]
3. Glycosaminoglycans and protein disulfide isomerase-mediated reduction of HIV Env.
Barbouche R; Lortat-Jacob H; Jones IM; Fenouillet E
Mol Pharmacol; 2005 Apr; 67(4):1111-8. PubMed ID: 15644496
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin-1 and protein disulfide isomerase catalyze the reduction of similar disulfides in HIV gp120.
Reiser K; François KO; Schols D; Bergman T; Jörnvall H; Balzarini J; Karlsson A; Lundberg M
Int J Biochem Cell Biol; 2012 Mar; 44(3):556-62. PubMed ID: 22230366
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry.
Gallina A; Hanley TM; Mandel R; Trahey M; Broder CC; Viglianti GA; Ryser HJ
J Biol Chem; 2002 Dec; 277(52):50579-88. PubMed ID: 12218051
[TBL] [Abstract][Full Text] [Related]
6. Progress in targeting HIV-1 entry.
Ryser HJ; Flückiger R
Drug Discov Today; 2005 Aug; 10(16):1085-94. PubMed ID: 16182193
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion.
Abrahamyan LG; Markosyan RM; Moore JP; Cohen FS; Melikyan GB
J Virol; 2003 May; 77(10):5829-36. PubMed ID: 12719576
[TBL] [Abstract][Full Text] [Related]
8. Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication.
Auwerx J; Isacsson O; Söderlund J; Balzarini J; Johansson M; Lundberg M
Int J Biochem Cell Biol; 2009 Jun; 41(6):1269-75. PubMed ID: 19038358
[TBL] [Abstract][Full Text] [Related]
9. Disulfide reduction in CD4 domain 1 or 2 is essential for interaction with HIV glycoprotein 120 (gp120), which impairs thioredoxin-driven CD4 dimerization.
Cerutti N; Killick M; Jugnarain V; Papathanasopoulos M; Capovilla A
J Biol Chem; 2014 Apr; 289(15):10455-10465. PubMed ID: 24550395
[TBL] [Abstract][Full Text] [Related]
10. The catalytic activity of protein disulfide isomerase is involved in human immunodeficiency virus envelope-mediated membrane fusion after CD4 cell binding.
Fenouillet E; Barbouche R; Courageot J; Miquelis R
J Infect Dis; 2001 Mar; 183(5):744-52. PubMed ID: 11181151
[TBL] [Abstract][Full Text] [Related]
11. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.
Alsahafi N; Debbeche O; Sodroski J; Finzi A
PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of HIV-1 gp120-CD4 receptor complex through targeted interchain disulfide exchange.
Cerutti N; Mendelow BV; Napier GB; Papathanasopoulos MA; Killick M; Khati M; Stevens W; Capovilla A
J Biol Chem; 2010 Aug; 285(33):25743-52. PubMed ID: 20538591
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction.
Ryser HJ; Levy EM; Mandel R; DiSciullo GJ
Proc Natl Acad Sci U S A; 1994 May; 91(10):4559-63. PubMed ID: 8183947
[TBL] [Abstract][Full Text] [Related]
14. Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion.
Ou W; Silver J
Virology; 2006 Jul; 350(2):406-17. PubMed ID: 16507315
[TBL] [Abstract][Full Text] [Related]
15. Snapshot of the interaction between HIV envelope glycoprotein 120 and protein disulfide isomerase.
Wang Z; Zhou Z; Guo ZY; Chi CW
Acta Biochim Biophys Sin (Shanghai); 2010 May; 42(5):358-62. PubMed ID: 20458450
[TBL] [Abstract][Full Text] [Related]
16. Stabilizing exposure of conserved epitopes by structure guided insertion of disulfide bond in HIV-1 envelope glycoprotein.
Kassa A; Dey AK; Sarkar P; Labranche C; Go EP; Clark DF; Sun Y; Nandi A; Hartog K; Desaire H; Montefiori D; Carfi A; Srivastava IK; Barnett SW
PLoS One; 2013; 8(10):e76139. PubMed ID: 24146829
[TBL] [Abstract][Full Text] [Related]
17. Mapping of domains on HIV envelope protein mediating association with calnexin and protein-disulfide isomerase.
Papandréou MJ; Barbouche R; Guieu R; Rivera S; Fantini J; Khrestchatisky M; Jones IM; Fenouillet E
J Biol Chem; 2010 Apr; 285(18):13788-96. PubMed ID: 20202930
[TBL] [Abstract][Full Text] [Related]
18. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
19. Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.
Lin G; Baribaud F; Romano J; Doms RW; Hoxie JA
J Virol; 2003 Jan; 77(2):931-42. PubMed ID: 12502809
[TBL] [Abstract][Full Text] [Related]
20. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.
Doranz BJ; Baik SS; Doms RW
J Virol; 1999 Dec; 73(12):10346-58. PubMed ID: 10559353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
